For example, T-tau has not discriminated between healthy controls and MCI in multiple studies, where elevated levels were only observed in AD dementia, with considerable overlap between groups (Zetterberg et al., 2013; Mattsson et al., 2016; Mielke et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.